1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Bhaskaran, R.
Huang, C.C.
Chang, K.D.
Yu, C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
269
23500
23508
8089116
Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins.
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6760.242
CARDIOTOXIN II
1
man
polymer
no
no
LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN
LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Chinese cobra
Naja
sample
8656
Naja atra
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-05-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1994-03-12
REL
1
BRUNGER
refinement
X-PLOR
LEU
1
n
1
LEU
1
A
LYS
2
n
2
LYS
2
A
CYS
3
n
3
CYS
3
A
ASN
4
n
4
ASN
4
A
LYS
5
n
5
LYS
5
A
LEU
6
n
6
LEU
6
A
VAL
7
n
7
VAL
7
A
PRO
8
n
8
PRO
8
A
LEU
9
n
9
LEU
9
A
PHE
10
n
10
PHE
10
A
TYR
11
n
11
TYR
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
CYS
14
n
14
CYS
14
A
PRO
15
n
15
PRO
15
A
ALA
16
n
16
ALA
16
A
GLY
17
n
17
GLY
17
A
LYS
18
n
18
LYS
18
A
ASN
19
n
19
ASN
19
A
LEU
20
n
20
LEU
20
A
CYS
21
n
21
CYS
21
A
TYR
22
n
22
TYR
22
A
LYS
23
n
23
LYS
23
A
MET
24
n
24
MET
24
A
PHE
25
n
25
PHE
25
A
MET
26
n
26
MET
26
A
VAL
27
n
27
VAL
27
A
SER
28
n
28
SER
28
A
ASN
29
n
29
ASN
29
A
LEU
30
n
30
LEU
30
A
THR
31
n
31
THR
31
A
VAL
32
n
32
VAL
32
A
PRO
33
n
33
PRO
33
A
VAL
34
n
34
VAL
34
A
LYS
35
n
35
LYS
35
A
ARG
36
n
36
ARG
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ILE
39
n
39
ILE
39
A
ASP
40
n
40
ASP
40
A
VAL
41
n
41
VAL
41
A
CYS
42
n
42
CYS
42
A
PRO
43
n
43
PRO
43
A
LYS
44
n
44
LYS
44
A
ASN
45
n
45
ASN
45
A
SER
46
n
46
SER
46
A
ALA
47
n
47
ALA
47
A
LEU
48
n
48
LEU
48
A
VAL
49
n
49
VAL
49
A
LYS
50
n
50
LYS
50
A
TYR
51
n
51
TYR
51
A
VAL
52
n
52
VAL
52
A
CYS
53
n
53
CYS
53
A
CYS
54
n
54
CYS
54
A
ASN
55
n
55
ASN
55
A
THR
56
n
56
THR
56
A
ASP
57
n
57
ASP
57
A
ARG
58
n
58
ARG
58
A
CYS
59
n
59
CYS
59
A
ASN
60
n
60
ASN
60
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
HE1
HB3
TYR
TYR
22
51
0.92
1
A
A
HG22
HD3
VAL
PRO
7
8
0.94
1
A
A
O
H
ASP
CYS
57
59
1.05
1
A
A
HD22
HD21
LEU
ASN
20
55
1.09
1
A
A
HB3
H
LYS
THR
12
13
1.19
1
A
A
HD21
HB2
LEU
ASN
20
55
1.20
1
A
A
HB3
H
ASP
ARG
57
58
1.23
1
A
A
H
HD2
VAL
PRO
7
8
1.29
1
A
A
HD3
NH1
LYS
ARG
23
36
1.39
1
A
A
O
HE1
VAL
TYR
49
51
1.40
1
A
A
H
O
LYS
ASN
2
60
1.46
1
A
A
HA
C
LEU
ASN
1
60
1.48
1
A
A
C
HD1
LYS
TYR
50
51
1.56
1
A
A
O
HD22
ASN
ASN
19
60
1.57
1
A
A
HG2
O
LYS
CYS
18
38
1.58
1
A
A
O
HE1
VAL
PHE
7
10
1.59
1
A
A
O
N
ASP
CYS
57
59
1.63
1
A
A
N
O
LYS
ASN
2
60
1.63
1
A
A
C
O
LEU
ASN
1
60
1.77
1
A
A
CA
O
LEU
ASN
1
60
1.89
1
A
A
O
CE1
VAL
PHE
7
10
2.03
1
A
ARG
36
0.160
SIDE CHAIN
1
A
ARG
58
0.315
SIDE CHAIN
1
A
LEU
6
66.33
-144.42
1
A
VAL
7
-126.13
-51.40
1
A
LEU
9
-134.42
-40.23
1
A
PHE
10
59.90
177.72
1
A
TYR
11
-140.94
-90.06
1
A
LYS
12
158.24
-113.05
1
A
ALA
16
87.88
135.87
1
A
ASN
19
-154.83
-23.09
1
A
PHE
25
-160.63
-166.11
1
A
SER
28
-158.16
-60.92
1
A
ASN
29
-123.75
-61.51
1
A
LEU
30
-146.98
59.50
1
A
THR
31
54.56
72.12
1
A
LYS
44
70.59
164.41
1
A
ASN
45
-157.57
-131.50
1
A
SER
46
178.74
-130.38
1
A
ALA
47
-144.23
-23.86
1
A
ASN
55
-159.69
42.05
1
A
THR
56
-162.40
94.22
1
A
ASP
57
63.78
-133.29
1
A
ARG
58
-14.14
-11.61
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
CARDIOTOXIN II (NMR, MINIMIZED AVERAGE STRUCTURE)
CARDIOTOXIN II FROM TAIWAN COBRA VENOM, NAJA NAJA ATRA: STRUCTURE IN SOLUTION AND COMPARISION AMONG HOMOLOGOUS CARDIOTOXINS
1
Y
N
disulf
2.020
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
2.019
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.021
A
CYS
42
A
SG
CYS
42
1_555
A
CYS
53
A
SG
CYS
53
1_555
disulf
2.020
A
CYS
54
A
SG
CYS
54
1_555
A
CYS
59
A
SG
CYS
59
1_555
CARDIOTOXIN
CARDIOTOXIN
CTX2_NAJAT
UNP
1
1
P01442
MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRC
N
22
81
1CRE
1
60
P01442
A
1
1
60
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
2
A
LYS
2
A
ASN
4
A
ASN
4
A
TYR
11
A
TYR
11
A
THR
13
A
THR
13
A
LEU
20
A
LEU
20
A
PHE
25
A
PHE
25
A
LYS
35
A
LYS
35
A
ILE
39
A
ILE
39
A
LYS
50
A
LYS
50
A
CYS
54
A
CYS
54
1
P 1